These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29403994)

  • 21. Efficacy and tolerability of a new nasal spray formulation containing hyaluronate and tobramycin in cystic fibrosis patients with bacterial rhinosinusitis.
    Di Cicco M; Alicandro G; Claut L; Cariani L; Luca N; Defilippi G; Costantini D; Colombo C
    J Cyst Fibros; 2014 Jul; 13(4):455-60. PubMed ID: 24656944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of drying method and formulation on the physical properties and stability of methionyl human growth hormone in the amorphous solid state.
    Abdul-Fattah AM; Lechuga-Ballesteros D; Kalonia DS; Pikal MJ
    J Pharm Sci; 2008 Jan; 97(1):163-84. PubMed ID: 17722086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design of a Topically Applied Gel Spray Formulation with Ivermectin Using a Novel Low Molecular Weight Gelling Agent, Palmitoyl-Glycine-Histidine, to Treat Scabies.
    Dahlizar S; Futaki M; Okada A; Kadhum WR; Todo H; Sugibayashi K
    Chem Pharm Bull (Tokyo); 2018; 66(3):327-333. PubMed ID: 29491265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and evaluation of nasal formulations of ketorolac.
    Quadir M; Zia H; Needham TE
    Drug Deliv; 2000; 7(4):223-9. PubMed ID: 11195429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of spray properties on intranasal deposition.
    Foo MY; Cheng YS; Su WC; Donovan MD
    J Aerosol Med; 2007; 20(4):495-508. PubMed ID: 18158721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nasal Administration and Plasma Pharmacokinetics of Parathyroid Hormone Peptide PTH 1-34 for the Treatment of Osteoporosis.
    Pearson RG; Masud T; Blackshaw E; Naylor A; Hinchcliffe M; Jeffery K; Jordan F; Shabir-Ahmed A; King G; Lewis AL; Illum L; Perkins AC
    Pharmaceutics; 2019 Jun; 11(6):. PubMed ID: 31181662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of a Thermosensitive In Situ Gel of Chitosan-Based Nasal Spray Loaded with Tranexamic Acid for Localised Treatment of Nasal Wounds.
    Gholizadeh H; Messerotti E; Pozzoli M; Cheng S; Traini D; Young P; Kourmatzis A; Caramella C; Ong HX
    AAPS PharmSciTech; 2019 Sep; 20(7):299. PubMed ID: 31482286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of formulation variables and breathing patterns on the site of nasal deposition in an anatomically correct model.
    Guo Y; Laube B; Dalby R
    Pharm Res; 2005 Nov; 22(11):1871-8. PubMed ID: 16091994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A priori performance prediction in pharmaceutical wet granulation: testing the applicability of the nucleation regime map to a formulation with a broad size distribution and dry binder addition.
    Kayrak-Talay D; Litster JD
    Int J Pharm; 2011 Oct; 418(2):254-64. PubMed ID: 21530625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spray-drying of inhalable, multifunctional formulations for the treatment of biofilms formed in cystic fibrosis.
    Lababidi N; Ofosu Kissi E; Elgaher WAM; Sigal V; Haupenthal J; Schwarz BC; Hirsch AKH; Rades T; Schneider M
    J Control Release; 2019 Nov; 314():62-71. PubMed ID: 31654686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of deposition from nasal spray devices using a computational fluid dynamics model of the human nasal passages.
    Kimbell JS; Segal RA; Asgharian B; Wong BA; Schroeter JD; Southall JP; Dickens CJ; Brace G; Miller FJ
    J Aerosol Med; 2007; 20(1):59-74. PubMed ID: 17388754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spray drying ternary amorphous solid dispersions of ibuprofen - An investigation into critical formulation and processing parameters.
    Ziaee A; Albadarin AB; Padrela L; Faucher A; O'Reilly E; Walker G
    Eur J Pharm Biopharm; 2017 Nov; 120():43-51. PubMed ID: 28822874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selection of excipient, solvent and packaging to optimize the performance of spray-dried formulations: case example fenofibrate.
    Hugo M; Kunath K; Dressman J
    Drug Dev Ind Pharm; 2013 Feb; 39(2):402-12. PubMed ID: 22591213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of zolmitriptan transfersomes by Box-Behnken design for nasal delivery: in vitro and in vivo evaluation.
    Pitta SK; Dudhipala N; Narala A; Veerabrahma K
    Drug Dev Ind Pharm; 2018 Mar; 44(3):484-492. PubMed ID: 29124986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elucidation of Formulation and Delivery Device-Related Effects on In Vitro Performance of Nasal Spray with Implication to Rational Product Specification Identification.
    Grmaš J; Stare K; Božič D; Injac R; Dreu R
    J Aerosol Med Pulm Drug Deliv; 2017 Aug; 30(4):230-246. PubMed ID: 28075184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emulsion formulations of testosterone for nasal administration.
    Ko KT; Needham TE; Zia H
    J Microencapsul; 1998; 15(2):197-205. PubMed ID: 9532525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Field activity and storage stability of Anagrapha falcifera nucleopolyhedrovirus (AfMNPV) in spray-dried lignin-based formulations.
    Behle RW; Tamez-Guerra P; McGuire MR
    J Econ Entomol; 2003 Aug; 96(4):1066-75. PubMed ID: 14503576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel nano-cellulose excipient for generating non-Newtonian droplets for targeted nasal drug delivery.
    Young PM; Traini D; Ong HX; Granieri A; Zhu B; Scalia S; Song J; Spicer PT
    Drug Dev Ind Pharm; 2017 Oct; 43(10):1729-1733. PubMed ID: 28581833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spray pattern and droplet size analyses for high-shear viscosity determination of aqueous suspension corticosteroid nasal sprays.
    Pennington J; Pandey P; Tat H; Willson J; Donovan B
    Drug Dev Ind Pharm; 2008 Sep; 34(9):923-9. PubMed ID: 18800252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recommendations for the standardisation of oxytocin nasal administration and guidelines for its reporting in human research.
    Guastella AJ; Hickie IB; McGuinness MM; Otis M; Woods EA; Disinger HM; Chan HK; Chen TF; Banati RB
    Psychoneuroendocrinology; 2013 May; 38(5):612-25. PubMed ID: 23265311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.